Understanding the Rapidly Evolving Science and Best Practices in Multiple Myeloma

Understanding the Rapidly Evolving Science and Best Practices in Multiple Myeloma is organized by Horizon CME.

Activity Launch Date: 2/18/2020
Expiration Date: 2/18/2021

Accreditation:
ANCC
The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Upon completion, NPs and RNs will be awarded up to 1.0 contact hours and up to 0.75 pharmacology hours.

Credit Designation
Horizon CME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description:
Multiple myeloma is the second-most common blood cancer in the United States, with an estimated 32,110 new cases and 12,960 related deaths anticipated in 2019.  Despite substantial progress in treatment, prognosis and survival remain suboptimal in this disease, which is marked by substantial morbidity and reduced quality of life. Providers who participate in focused and expert-guided education will be better prepared to implement best practices and to help patients make better-informed decisions about their care in collaboration with their health care team. 

Objectives:
Upon completion of this activity, participants should be able to:
• Describe the burden of multiple myeloma in the US
• Apply current best practices for myeloma assessment based current standards and emerging advances
• Select optimal treatment for multiple myeloma based on current guideline recommendations and expert opinion regarding emerging data
• Summarize the latest developments in myeloma treatment that have changed management options for patients with myeloma
• Devise treatment plans for multiple myeloma with consideration for age/frailty and other patient and disease characteristics.